ArticleJournal of inflammation research2025
Clinical Value of Lymphocyte Count in Risk Prediction of Papillary Thyroid Carcinoma: A Case-Control Study in a Chinese Population.
Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A nomogram based on immunohistochemistry and lymphocyte-to-monocyte ratio for predicting risk stratification in endometrial carcinoma.Oncology letters · 2026Article
- A Comprehensive Exploration of Thyroid Nodules Diagnosis, Epidemiology and Pathophysiology with Emphasis on the Role of Traditional Chinese Medicine Treatment.International journal of general medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to evaluate the association between preoperative peripheral blood lymphocyte count and the risk of papillary thyroid carcinoma (PTC) in a Chinese population using a case-control design. Methods: A retrospective analysis was conducted on 1832 patients who underwent thyroid surgery, including 1007 diagnosed with benign thyroid nodules and 825 with PTC. Clinical parameters, including lymphocyte count, nodule volume, thyroid function, and thyroid autoantibody levels, were assessed. Multivariate regression and stratified analyses were conducted to examine the relationship between lymphocyte count and PTC risk. Results: The mean lymphocyte count was significantly higher in patients with PTC compared to those with benign thyroid nodules (1.20 ± 0.63 vs 1.87 ± 0.53, Conclusion: Lymphocyte count may serve as a potential predictor of PTC risk. This finding may provide new insights into early clinical risk stratification and personalized screening strategies in the management of PTC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.